Literature DB >> 4697661

Disturbed hepatic function during isoniazid chemoprophylaxis. Monitoring the hepatic function of 427 hospital employees receiving isoniazid chemoprophylaxis for tuberculosis.

W C Bailey, S L Taylor, H E Dascomb, H B Greenberg, M M Ziskind.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4697661     DOI: 10.1164/arrd.1973.107.4.523

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  8 in total

1.  Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.

Authors:  J E Lewis; P Mello; C M Knauer
Journal:  West J Med       Date:  1975-05

Review 2.  Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status.

Authors:  F Durand; G Jebrak; D Pessayre; M Fournier; J Bernuau
Journal:  Drug Saf       Date:  1996-12       Impact factor: 5.606

3.  Isoniazid liver injury during chemoprophylaxis in children.

Authors:  P Spyridis; C Sinaniotis; I Papadea; L Oreopoulos; S Hadjiyiannis; C Papadatos
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

Review 4.  BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment.

Authors: 
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

5.  Lymphocyte-mediated cytotoxicity in isoniazid-associated hepatitis.

Authors:  R J Warrington; S L Olivier
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

6.  Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.

Authors:  S R Salpeter
Journal:  West J Med       Date:  1993-11

7.  Evaluation of isoniazid-associated hepatitis by immunological tests.

Authors:  R J Warrington; K S Tse; B A Gorski; R Schwenk; A H Sehon
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

Review 8.  Tuberculosis chemoprophylaxis.

Authors:  S Salpeter
Journal:  West J Med       Date:  1992-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.